BioSpace News Archive

Lisata Therapeutics, Inc. announced today that it will report its financial results for the second quarter ended June 30, 2023, on Monday, August 14, 2023, after market trading and will host a conference call at 8:30 a.m. Eastern time the following morning.

ALR Technologies SG Ltd., the diabetes management company, announces plans to launch the GluCurve Pet CGM in Canada during Q3 2023 with a direct to veterinarian clinic sales model through GluCurve.ca.

GERO and FOXO Technologies Inc. , today announced the commencement of discussions to form a strategic collaboration between the two companies.

Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or “the Company”) announced that the results of an independent pilot phase 2 study of crofelemer for the management of neratinib-associated diarrhea in patients with HER2+ early-stage breast cancer indicate that crofelemer, the Company’s FDA approved drug, may be effective for the management of neratinib-induced diarrhea.

Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today reported financial results for the three months ended June 30, 2023.

A report by Precedence Research examines the global cell expansion market size is estimated to reach around USD 50.82 billion by 2032 and represents a CAGR of 12.5% from 2023 to 2032.

Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced enhancements to the GeneSight® Psychotropic test, a pharmacogenomic test for mental health medications.

Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today reported financial results and provided business updates for the second quarter ended June 30, 2023.

Windtree Therapeutics, Inc., a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, reported financial results for the second quarter ended June 30, 2023 and provided key business updates.

Stryker (NYSE:SYK) will participate in the 2023 Wells Fargo Securities Healthcare Conference on Thursday, September 7, 2023.